QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 

   

 

This Article
* Extract Freely available
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when eLetters are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via ISI Web of Science (21)
* Citing Articles via Google Scholar
Google Scholar
* Articles by Scherer, F.M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Scherer, F.M.
Related Collections
* Pharmaceuticals
* State/Local Issues

The Link Between Gross Profitability And Pharmaceutical R&D Spending

F.M. Scherer


Figure 1
View larger version (16K):

[in a new window]
 
EXHIBIT 1 Pharmaceutical Industry Research And Development (R&D) Outlays Against Exponential Time Trend, 1962–1996

 

Figure 2
View larger version (11K):

[in a new window]
 
EXHIBIT 2 Pharmaceutical Industry Gross Margins Against Exponential Time Trend, 1962–1996

 

Figure 3
View larger version (19K):

[in a new window]
 
EXHIBIT 3 Percentage Deviations From Trend For Pharmaceutical Industry Gross Margins And Research And Development (R&D) Outlays, 1962–1996

 

Figure 4
View larger version (18K):

[in a new window]
 
EXHIBIT 4 Percentage Deviations In Research And Development (R&D) As A Percentage Of Sales And Price-Cost Margins As A Percentage Of Census Sales, 1962–1996

 


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?



Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help

© 2001-2001 Project HOPE–The People-to-People Organization
Terms and Policies